Tech Company Financing Transactions
Monod Bio Funding Round
Monod Bio, operating out of Seattle, raised $25 million from Matrix Capital Management, Boom Capital and Cercano Management.
Transaction Overview
Company Name
Announced On
8/16/2022
Transaction Type
Venture Equity
Amount
$25,000,000
Round
Seed
Investors
Proceeds Purpose
The company intends to use the funds to advance its platform for the rapid development of one-step biosensors and reporter proteins to detect targets for applications in biotechnology and medicine, and to double the size of its research and engineering teams in the coming 18 months.
Company Information
Company Status
Private & Independent
Industry
Life Sciences
Mailing Address
Fluke Hall - University of Washington 4000 Mason Rd
Seattle, WA 98105
USA
Seattle, WA 98105
USA
Phone
Website
Email Address
Overview
Monod Bio is a pioneer company in the design of de novo protein biosensors. Our innovative biosensor platform technology takes advantage of the most recent advances in computational protein engineering to create highly modular biosensing nanoswitches that enable rapid, sensitive, and inexpensive analytical assays. Our visionary founding team and state-of-the-art technology position Monod Bio at the forefront of biosensor innovation, and we welcome exceptional individuals to join us in this journey.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Daniel Silva
Chief Operating Officer
David Shoultz
Chief Scientific Officer
Alfredo Rubio
Browse more venture capital transactions:
Prev: 8/15/2022: Flow venture capital transaction
Next: 8/16/2022: Violet venture capital transaction
Share this article
About Our VC Transactions Data
Our team works diligently to report on every notable VC transaction. All VC database entries reported here are sourced from a variety of public sources. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs